Global Pharmaceuticals & Biotech Most Popular Stocks

Jiangsu Lianhuan Pharmaceutical

Market Cap: CN¥5.4b

Manufactures and sells pharmaceuticals, preparations, and API products in China and internationally.

Shandong Sinobioway Biomedicine

Market Cap: CN¥5.3b

Shandong Sinobioway Biomedicine Co., Ltd.

Jiangxi Fushine Pharmaceutical

Market Cap: CN¥5.3b

Engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally.

Septerna

Market Cap: US$746.8m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Chong Kun Dang Pharmaceutical

Market Cap: ₩1.1t

Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

Hunan Fangsheng Pharmaceutical

Market Cap: CN¥5.3b

Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.

Mind Medicine (MindMed)

Market Cap: US$743.4m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Luoxin Pharmaceuticals Group Stock

Market Cap: CN¥5.3b

Luoxin Pharmaceuticals Group Stock Co., Ltd.

Nanobiotix

Market Cap: €634.5m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Xencor

Market Cap: US$736.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Hinova Pharmaceuticals

Market Cap: CN¥5.2b

A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.

Savara

Market Cap: US$731.1m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Iovance Biotherapeutics

Market Cap: US$730.9m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Anavex Life Sciences

Market Cap: US$730.1m

Operates as a biopharmaceutical company.

Hunan Jingfeng PharmaceuticalLtd

Market Cap: CN¥5.2b

Manufactures and sells chemical drugs and biological agents in China.

Kura Oncology

Market Cap: US$725.6m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Myriad Genetics

Market Cap: US$722.0m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests.

Sunmax Biotechnology

Market Cap: NT$22.0b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

Hefei Lifeon Pharmaceutical

Market Cap: CN¥5.1b

Engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients.

Vir Biotechnology

Market Cap: US$719.6m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

Guizhou Sanli PharmaceuticalLtd

Market Cap: CN¥5.1b

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.

Akebia Therapeutics

Market Cap: US$718.5m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Fuan Pharmaceutical (Group)

Market Cap: CN¥5.1b

Research and develops, produces, and sells chemical drugs in the People's Republic of China.

R&G PharmaStudies

Market Cap: CN¥5.1b

Operates as a clinical trial outsourcing service provider in China and internationally.

Tibet Weixinkang Medicine

Market Cap: CN¥5.0b

Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.

Newland Pharmaceutical

Market Cap: CN¥5.0b

Engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China.

Qianjiang Yongan Pharmaceutical

Market Cap: CN¥5.0b

Qianjiang Yongan Pharmaceutical Co., Ltd.

ArriVent BioPharma

Market Cap: US$696.6m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Basilea Pharmaceutica

Market Cap: CHF 555.4m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Jinhe Biotechnology

Market Cap: CN¥5.0b

Produces and sells veterinary medicines in China.

Hubei Biocause Heilen Pharmaceutical

Market Cap: CN¥5.0b

Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Theravance Biopharma

Market Cap: US$694.5m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Zhejiang Orient Gene Biotech

Market Cap: CN¥4.9b

Researches and develops, produces, and sells in vitro diagnostic products worldwide.

Beijing Beilu Pharmaceutical

Market Cap: CN¥4.9b

Engages in the research, development, production, and sale of pharmaceutical products in China.

Maravai LifeSciences Holdings

Market Cap: US$686.9m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Prime Medicine

Market Cap: US$684.3m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.